CU20090190A7 - NOVELED SALTS OF PIPERAZINE AS ANTAGONISTS D3 / D2 - Google Patents

NOVELED SALTS OF PIPERAZINE AS ANTAGONISTS D3 / D2

Info

Publication number
CU20090190A7
CU20090190A7 CU20090190A CU20090190A CU20090190A7 CU 20090190 A7 CU20090190 A7 CU 20090190A7 CU 20090190 A CU20090190 A CU 20090190A CU 20090190 A CU20090190 A CU 20090190A CU 20090190 A7 CU20090190 A7 CU 20090190A7
Authority
CU
Cuba
Prior art keywords
salts
noveled
piperazine
antagonists
solvates
Prior art date
Application number
CU20090190A
Other languages
Spanish (es)
Inventor
Istvan Greiner
Ferenc Seboek
Laszlo Gzibula
Csongor Eva Againe
Gyoergy Domany
Original Assignee
Richter Gedeon Nyrt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Nyrt filed Critical Richter Gedeon Nyrt
Priority to CU20090190A priority Critical patent/CU20090190A7/en
Publication of CU20090190A7 publication Critical patent/CU20090190A7/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención se refiere a sales novedosas monohidrocloruro, dihidrocloruro, monohidrobromuro, maleato y metanosulfonato de trans 4-{2-[4/(2,3-diclorofenil)-piperazin-1-il]-etil}-N,N-dimetilcarbamoil-ciclohexilamina y/o sus hidratos y/o solvatos. Además, la invención se refiere al proceso de preparación de sales y sus hidratos y/o solvatos, a su uso en el tratamiento y/o prevención de trastornos que requieren la modulación de receptores de dopamina y a composiciones farmacéuticas que la contienen.The present invention relates to novel salts monohydrochloride, dihydrochloride, monohydrobromide, maleate and trans 4- {2- [4 / (2,3-dichlorophenyl) -piperazin-1-yl] -ethyl} -N, N-dimethylcarbamoyl methanesulfonate -cyclohexylamine and / or its hydrates and / or solvates. In addition, the invention relates to the process of preparing salts and their hydrates and / or solvates, their use in the treatment and / or prevention of disorders that require the modulation of dopamine receptors and pharmaceutical compositions containing it.

CU20090190A 2009-11-10 2009-11-10 NOVELED SALTS OF PIPERAZINE AS ANTAGONISTS D3 / D2 CU20090190A7 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CU20090190A CU20090190A7 (en) 2009-11-10 2009-11-10 NOVELED SALTS OF PIPERAZINE AS ANTAGONISTS D3 / D2

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CU20090190A CU20090190A7 (en) 2009-11-10 2009-11-10 NOVELED SALTS OF PIPERAZINE AS ANTAGONISTS D3 / D2

Publications (1)

Publication Number Publication Date
CU20090190A7 true CU20090190A7 (en) 2011-07-11

Family

ID=44306221

Family Applications (1)

Application Number Title Priority Date Filing Date
CU20090190A CU20090190A7 (en) 2009-11-10 2009-11-10 NOVELED SALTS OF PIPERAZINE AS ANTAGONISTS D3 / D2

Country Status (1)

Country Link
CU (1) CU20090190A7 (en)

Similar Documents

Publication Publication Date Title
ECSP099772A (en) NOVELED SALTS OF PIPERAZINE AS ANTAGONISTS D3 / D2
NI200900202A (en) METABOLITES OF DERIVATIVES OF (TIO) - CARBAMOIL - CYCLOHEXANE.
CL2017000432A1 (en) Cathepsin c spirocyclic inhibitors
UY35377A (en) 1,3-OXAZIN-2-AMINA COMPOUNDS FUSED WITH PERFLUORATED CYCLOPROPYL AS BETA-SECRETASE INHIBITORS AND METHODS OF USE
MY148643A (en) Solvate and crystalline forms of carbamoyl-cyclohexane derivatives
MY155570A (en) 1, 3-disubstituted imidazolidin-2-one derivatives as inhibitors of cyp 17
MX2021003792A (en) Benzoquinoline inhibitors of vesicular monoamine transporter 2.
NI201500074A (en) TRANS-4- {2- [4- (2, 3-DICHLOROPHENYL) -PIPERAZIN-1-IL] -ETHYL} -N, N-DIMETHYLCARBAMOYL-CYCLOHEXYLAMINE FOR THE TREATMENT OF NEGATIVE SYMPTOMS OF SCHIZOPHRENIA.
AR082660A1 (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF RESPIRATORY AND INFLAMMATORY DISEASES
UY28765A1 (en) ACETILINIC PIPERAZINE COMPOUNDS AND THEIR USE AS ANTAGONISTS OF THE METABOTROPIC GLUTAMATE RECEPTOR
BR112017021277A2 (en) SYNTHESIS OF 1- [2- (2,4-DIMETHYL-PHENYLSULFANYL) -FENY] PYPERAZINE
CL2012003539A1 (en) Compounds derived from alkyl-piperazino-phenyl 4 (3h) one; Pharmaceutical composition and its use for the treatment of disorders associated with serotonergic receptors 5-ht1a and 5-ht2a, such as depression, anxiety, and sleep disorders.
BR112013002194A2 (en) use of 1- [2- (2,4-dimethylphenylsulfanyl) phenyl] piperazine and its pharmaceutically acceptable salts
CO2017005640A2 (en) 3- (4-isobutyl-2-methylphenyl) propanal precursor fragrance and compositions thereof
CU20090190A7 (en) NOVELED SALTS OF PIPERAZINE AS ANTAGONISTS D3 / D2
MX2020008745A (en) Indole and benzimidazole derivatives as dual 5-ht2a and 5-ht6 receptor antagonists.
UY29733A1 (en) ACETYLENE PIPERAZINS AS ANTAGONISTS OF METABOTROPIC GLUTAMATE RECEPTORS
MX2019001696A (en) Combination of histamine-3 receptor inverse agonists with acetylcholinesterase inhibitors.
PL407397A1 (en) 3-(4-bromobenzoyl)-4-hydroxy-2-{2-[2-pyrimidyl)piperazin-1-yl]-2-oxoethyl}-2H-1,2-benzothiazine 1,1-dioxide with anti-inflammatory and analgesic activity and method for producing it
PL407396A1 (en) 3-benzyl)-4-hydroxy-2-{2-[4-methoxyphenyl)piperazin-1-yl]2-oxoethyl}-2H-1,2-benzothiazine 1,1-dioxide with anti-inflammatory and analgesic activity and method for producing it